Athanor Capital, LP Adverum Biotechnologies, Inc. Transaction History

Athanor Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.36 - $10.56 $65,573 - $206,088	-19,516 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$9.26 - $14.36 $299,264 - $464,086	-32,318 Reduced 62.35%	19,516 $192,000
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $312,793 - $453,296	31,788 Added 158.58%	51,834 $562,000
Q3 2020 Nov 16, 2020	SELL	$10.3 - $21.64 $203,569 - $427,692	-19,764 Reduced 49.65%	20,046 $206,000
Q2 2020 Aug 13, 2020	BUY	$8.53 - $25.64 $339,579 - $1.02 Million	39,810 New	39,810 $831,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $612M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.